Tower Research Capital (TRC)’s BIO-key International BKYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-175
| Closed | -$929 | – | 5234 |
|
|
2026
Q1 | $929 | Sell |
175
-1
| -0.6% | -$6 | ﹤0.01% | 4752 |
|
|
2025
Q4 | $949 | Sell |
176
-1
| -0.6% | -$8 | ﹤0.01% | 4791 |
|
|
2025
Q3 | $1.27K | Sell |
177
-3
| -2% | -$23 | ﹤0.01% | 4835 |
|
|
2025
Q2 | $1.47K | Hold |
180
| – | – | ﹤0.01% | 4808 |
|
|
2025
Q1 | $1.42K | Sell |
180
-511
| -74% | -$6.49K | ﹤0.01% | 4708 |
|
|
2024
Q4 | $11.8K | Buy |
691
+170
| +33% | +$1.65K | ﹤0.01% | 3675 |
|
|
2024
Q3 | $5K | Sell |
521
-71
| -12% | -$1.02K | ﹤0.01% | 4349 |
|
|
2024
Q2 | $9.71K | Buy |
592
+118
| +25% | +$2.04K | ﹤0.01% | 4218 |
|
|
2024
Q1 | $9.95K | Sell |
474
-144
| -23% | -$2.91K | ﹤0.01% | 3771 |
|
|
2023
Q4 | $18.5K | Buy |
618
+602
| +3,763% | +$26.2K | ﹤0.01% | 3699 |
|
|
2023
Q3 | $1.59K | Hold |
16
| – | – | ﹤0.01% | 5301 |
|
|
2023
Q2 | $2.21K | Hold |
16
| – | – | ﹤0.01% | 5230 |
|
|
2023
Q1 | $2K | Hold |
16
| – | – | ﹤0.01% | 5312 |
|
|
2022
Q4 | $2K | Buy |
+16
| New | +$3.48K | ﹤0.01% | 5330 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | -$1K | – | 6094 |
|
|
2021
Q4 | $1K | Buy |
+2
| New | +$1.01K | ﹤0.01% | 5789 |
|
|
2021
Q2 | – | Sell |
-6
| Closed | -$4K | – | 5474 |
|
|
2021
Q1 | $4K | Sell |
6
-3
| -33% | -$2.17K | ﹤0.01% | 4757 |
|
|
2020
Q4 | $6K | Buy |
+9
| New | +$5.7K | ﹤0.01% | 4535 |
|
Tower Research Capital (TRC)'s BKYI Position: Q2 2026 in Review
Tower Research Capital (TRC) sold out of BIO-key International (BKYI) in Q2 2026, closing a stake of 175 shares — an estimated $929 sold.
Tower Research Capital (TRC) first reported a position in BKYI in Q4 2020 and held it in 17 quarters. The position peaked at $18.5K in Q4 2023. 0 funds tracked by Wall St. Rank hold BKYI as of Q2 2026.
- Tower Research Capital (TRC) reported no remaining BIO-key International position as of Q2 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 175 BIO-key International shares in Q2 2026, an estimated $929.
- Tower Research Capital (TRC) first reported a position in BIO-key International in Q4 2020 and held it in 17 quarters.
- Tower Research Capital (TRC)'s BIO-key International position peaked at $18.5K in Q4 2023.
- 0 funds tracked by Wall St. Rank held BIO-key International as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.